Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XIENCE 28 Global Study

NCT03355742 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03355742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03355742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XIENCE 28 Global Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
February 9, 2018
Completion date
April 30, 2020
Enrollment
963 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, bleeding disorder, coagulation disorder, coronary artery disease, hematological disease, renal insufficiency, stroke hemorrhagic, stroke, ischemic, thrombocytopenia